Valuation : Dermapharm Holding SE

Market Cap 1.85B 2.15B 1.75B 1.59B 2.98B 205B 3B 20.84B 8.01B 105B 8.08B 7.9B 330B P/E 2026 *
14.3x
P/E 2027 * 12.6x
Enterprise Value 2.66B 3.09B 2.52B 2.29B 4.29B 295B 4.31B 29.97B 11.52B 150B 11.61B 11.36B 475B EV / Sales 2026 *
2.2x
EV / Sales 2027 * 2.02x
Free-Float
10.7%
Yield 2026 *
2.73%
Yield 2027 * 3.05%
1 day-2.35%
1 week-5.56%
Current month-4.10%
1 month-6.62%
3 months-23.12%
6 months-8.22%
Current year-4.96%
1 week 37.35
Extreme 37.35
39.55
1 month 37.35
Extreme 37.35
42.15
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
5/14/26 A Buy

Chairman

380,000 0.7670%
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 150 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.35%-5.56%+13.51%-12.82% 2.15B
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.89%-5.74%+21.22%+35.03% 350.69B
Weighted average by Cap. -0.51%-4.42%+30.95%+54.90%

Financials

2026 *2027 *
Net sales 1.21B 1.4B 1.14B 1.04B 1.95B 134B 1.96B 13.59B 5.23B 68.18B 5.27B 5.15B 215B 1.25B 1.46B 1.19B 1.08B 2.02B 139B 2.03B 14.11B 5.42B 70.77B 5.47B 5.35B 224B
Net income 137M 159M 130M 118M 221M 15.22B 222M 1.54B 594M 7.74B 598M 585M 24.47B 155M 180M 147M 133M 250M 17.22B 251M 1.75B 672M 8.76B 677M 662M 27.69B
Net Debt 812M 942M 769M 697M 1.31B 90.01B 1.31B 9.13B 3.51B 45.79B 3.54B 3.46B 145B 687M 797M 650M 590M 1.11B 76.16B 1.11B 7.72B 2.97B 38.75B 2.99B 2.93B 122B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,619
Date Price Change Volume
11/09/26 €37.40 -2.35% 43,615
10/09/26 €38.30 -1.29% 29,073
09/09/26 €38.80 -0.39% 28,704
08/09/26 €38.95 +1.04% 31,315
07/09/26 €38.55 -2.65% 34,423
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
37.40EUR
Average target price
51.00EUR
Spread / Average Target
+36.36%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!